Biopolymer implants enhance the efficacy of adoptive T-cell therapy
Open Access
- 15 December 2014
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Biotechnology
- Vol. 33 (1), 97-101
- https://doi.org/10.1038/nbt.3104
Abstract
Delivery of T cells using an alginate polymer–based implant enhances the efficacy of cancer immunotherapy. Although adoptive T-cell therapy holds promise for the treatment of many cancers, its clinical utility has been limited by problems in delivering targeted lymphocytes to tumor sites, and the cells' inefficient expansion in the immunosuppressive tumor microenvironment. Here we describe a bioactive polymer implant capable of delivering, expanding and dispersing tumor-reactive T cells. The approach can be used to treat inoperable or incompletely removed tumors by situating implants near them or at resection sites. Using a mouse breast cancer resection model, we show that the implants effectively support tumor-targeting T cells throughout resection beds and associated lymph nodes, and reduce tumor relapse compared to conventional delivery modalities. In a multifocal ovarian cancer model, we demonstrate that polymer-delivered T cells trigger regression, whereas injected tumor-reactive lymphocytes have little curative effect. Scaffold-based T-cell delivery may provide a viable treatment option for inoperable tumors and reduce the rate of metastatic relapse after surgery.Keywords
This publication has 31 references indexed in Scilit:
- Ovarian cancer progression is controlled by phenotypic changes in dendritic cellsThe Journal of Experimental Medicine, 2012
- Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomasNature Neuroscience, 2011
- Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer ImmunotherapyClinical Cancer Research, 2011
- The Impact of Ex Vivo Clinical Grade Activation Protocols on Human T-cell Phenotype and Function for the Generation of Genetically Modified Cells for Adoptive Cell Transfer TherapyJournal of Immunotherapy, 2010
- Polysaccharide‐modified synthetic polymeric biomaterialsPeptide Science, 2010
- Coating of biomaterial scaffolds with the collagen-mimetic peptide GFOGER for bone defect repairBiomaterials, 2009
- In Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in MiceScience Translational Medicine, 2009
- Noninvasive detection of therapeutic cytolytic T cells with 18F–FHBG PET in a patient with gliomaNature Clinical Practice Oncology, 2008
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaNature Medicine, 2008
- Converting IL-15 to a superagonist by binding to soluble IL-15RαProceedings of the National Academy of Sciences of the United States of America, 2006